Home › Funds › JW Asset Management, LLC › TARS
JW Asset Management, LLC position in TARS
TARSUS PHARMACEUTICALS INC · Health Care
JW Asset Management, LLC reported holding 9,000 shares of TARS (TARSUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$707K, representing 0.30% of its reported portfolio and ranking #19 among its reported holdings. JW Asset Management, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How JW Asset Management, LLC's TARS position evolved
JW Asset Management, LLC first disclosed a stake in TARS in Q3 2026 at 9,000 shares (US$707K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 9.00K | $707.49K | New |
About TARS and 13F data
TARS (TARSUS PHARMACEUTICALS INC) is a Health Care company. 43 other funds we track also report a position in TARS — the largest reported positions include Deep Track Capital, LP (US$230.8M), RTW INVESTMENTS, LP (US$211.3M), Paradigm Biocapital Advisors LP (US$174.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TARS
- Deep Track Capital, LP 3.67M sh · $230.79M · Q2 2026
- RTW INVESTMENTS, LP 3.36M sh · $211.29M · Q2 2026
- Paradigm Biocapital Advisors LP 2.78M sh · $174.70M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.57M sh · $98.71M · Q2 2026
- Vestal Point Capital, LP 1.05M sh · $66.09M · Q2 2026
- Frazier Life Sciences Management, L.P. 728.64K sh · $45.86M · Q2 2026
- Tri Locum Partners LP 328.34K sh · $20.67M · Q2 2026
- MPM BioImpact LLC 322.01K sh · $20.27M · Q2 2026
More on JW Asset Management, LLC
FAQ
How long has JW Asset Management, LLC held TARS?
JW Asset Management, LLC has disclosed TARS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is JW Asset Management, LLC's current position in TARS?
As of Q3 2026, JW Asset Management, LLC holds 9.00K shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $707.49K, representing 0.30% of its reported portfolio and ranking #19.
Has JW Asset Management, LLC been buying or selling TARS?
In the latest 13F filing (Q3 2026), JW Asset Management, LLC newly opened its position in TARS.
Which other funds hold TARS?
Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.